Your browser is no longer supported. Please, upgrade your browser.
Settings
FLGT [NASD]
Fulgent Genetics, Inc.
Index- P/E6.24 EPS (ttm)14.85 Insider Own4.50% Shs Outstand28.83M Perf Week13.35%
Market Cap2.58B Forward P/E27.62 EPS next Y3.36 Insider Trans-7.80% Shs Float19.08M Perf Month12.84%
Income417.00M PEG- EPS next Q2.76 Inst Own36.30% Short Float27.48% Perf Quarter6.31%
Sales773.40M P/S3.34 EPS this Y38.10% Inst Trans2.14% Short Ratio6.24 Perf Half Y22.59%
Book/sh27.80 P/B3.33 EPS next Y-73.05% ROA81.60% Target Price87.00 Perf Year250.30%
Cash/sh14.70 P/C6.30 EPS next 5Y- ROE101.40% 52W Range25.03 - 189.89 Perf YTD77.91%
Dividend- P/FCF7.91 EPS past 5Y88.50% ROI36.50% 52W High-49.88% Beta1.52
Dividend %- Quick Ratio3.40 Sales past 5Y113.20% Gross Margin79.30% 52W Low280.23% ATR5.52
Employees429 Current Ratio3.40 Sales Q/Q4536.00% Oper. Margin71.70% RSI (14)64.06 Volatility5.60% 7.32%
OptionableYes Debt/Eq0.02 EPS Q/Q- Profit Margin53.90% Rel Volume0.81 Prev Close92.69
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout0.00% Avg Volume839.54K Price95.17
Recom2.50 SMA2010.60% SMA5018.46% SMA20024.63% Volume584,285 Change2.68%
Jan-08-21Downgrade Credit Suisse Neutral → Underperform $42 → $40
Nov-24-20Downgrade BTIG Research Buy → Neutral
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Nov-05-19Upgrade Piper Jaffray Neutral → Overweight
Mar-01-18Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Raymond James Outperform → Mkt Perform
Jul-26-21 10:59AM  
08:24AM  
Jul-19-21 04:45PM  
Jul-14-21 08:22AM  
Jul-13-21 09:48AM  
Jul-04-21 05:20AM  
Jun-29-21 06:08AM  
Jun-24-21 07:05AM  
Jun-22-21 07:15PM  
07:08PM  
06:45PM  
03:40PM  
02:10PM  
01:46PM  
11:42AM  
11:00AM  
09:45AM  
05:34AM  
Jun-21-21 10:38PM  
09:23PM  
03:11PM  
01:38PM  
01:30PM  
01:30PM  
01:28PM  
12:00PM  
11:13AM  
11:00AM  
09:44AM  
05:56AM  
Jun-20-21 01:23PM  
11:35AM  
11:10AM  
Jun-19-21 02:30PM  
12:00PM  
Jun-18-21 10:50PM  
07:30PM  
04:37PM  
02:04PM  
12:35PM  
11:55AM  
11:15AM  
11:00AM  
10:11AM  
Jun-10-21 06:40AM  
Jun-08-21 06:10AM  
May-29-21 12:45PM  
04:44AM  
May-18-21 05:49AM  
May-14-21 07:10AM  
May-10-21 08:00AM  
May-07-21 06:08AM  
01:31AM  
May-06-21 04:05PM  
02:45PM  
08:00AM  
May-05-21 01:28PM  
Apr-30-21 09:26AM  
Apr-27-21 06:24AM  
Apr-24-21 06:35AM  
Apr-23-21 03:03AM  
Apr-22-21 07:01AM  
06:20AM  
Apr-20-21 07:21AM  
Apr-17-21 06:20AM  
Apr-16-21 08:00AM  
Apr-13-21 07:08AM  
Apr-09-21 06:15PM  
Apr-05-21 08:37AM  
Apr-03-21 06:02AM  
Apr-01-21 09:18AM  
Mar-31-21 06:54AM  
06:04AM  
Mar-29-21 02:08PM  
Mar-25-21 07:02AM  
06:45AM  
Mar-24-21 06:20AM  
Mar-20-21 07:05AM  
Mar-18-21 03:40AM  
Mar-16-21 08:17AM  
06:01AM  
Mar-15-21 04:05PM  
Mar-14-21 07:02AM  
Mar-13-21 07:01AM  
Mar-10-21 10:06AM  
Mar-08-21 06:51AM  
Mar-07-21 08:27AM  
Mar-05-21 11:13AM  
08:00AM  
06:15AM  
06:01AM  
Mar-04-21 11:30PM  
05:40PM  
04:58PM  
04:05PM  
02:30PM  
Mar-02-21 07:36AM  
Feb-28-21 07:33AM  
Feb-26-21 02:00PM  
10:00AM  
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home COVID-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIM PAULCFO and TreasurerJun 04Sale74.2678958,588142,188Jun 04 06:38 PM
BOLGER JOHN CDirectorJun 03Sale74.171259,2712,000Jun 07 05:25 PM
KIM PAULCFO and TreasurerJun 02Sale71.3446132,886142,977Jun 04 06:38 PM
BOLGER JOHN CDirectorJun 01Option Exercise12.171,87622,8244,001Jun 03 05:41 PM
BOLGER JOHN CDirectorJun 01Sale71.411,876133,9662,125Jun 03 05:41 PM
Xie JianChief Operating OfficerMay 28Sale73.4664747,527337,394Jun 02 04:45 PM
KIM PAULCFO and TreasurerMay 26Sale72.9018,0001,312,119143,438May 27 07:07 PM
KIM PAULCFO and TreasurerMay 25Sale72.9410,358755,479161,438May 27 07:07 PM
Xie JianChief Operating OfficerMay 25Sale72.212,000144,412338,041May 27 06:58 PM
Xie JianChief Operating OfficerMay 20Sale74.481,00074,480340,041May 20 08:50 PM
Xie JianChief Operating OfficerMay 18Sale70.7193165,831341,041May 20 08:50 PM
KIM PAULCFO and TreasurerMay 18Sale70.711,15581,670171,796May 20 05:29 PM
Gao HanlinChief Scientific OfficerMay 18Sale70.7131522,274816,273May 20 05:27 PM
Xie JianChief Operating OfficerMar 15Sale104.103,000312,300342,476Mar 17 05:09 PM
BOLGER JOHN CDirectorMar 09Option Exercise5.243,12416,3843,499Mar 11 05:19 PM
Xie JianChief Operating OfficerMar 09Sale102.6562,0006,364,219345,476Mar 11 05:13 PM
BOLGER JOHN CDirectorMar 09Sale101.623,374342,882125Mar 11 05:19 PM
KIM PAULCFO and TreasurerDec 10Sale51.9416,958880,734174,563Dec 11 06:26 PM
KIM PAULCFO and TreasurerDec 09Sale51.6010,662550,189191,521Dec 11 06:26 PM
KIM PAULCFO and TreasurerDec 02Sale46.5829,9491,395,133202,183Dec 04 04:06 PM
Xie JianChief Operating OfficerDec 02Sale46.001,00046,000431,689Dec 02 06:03 PM
Xie JianChief Operating OfficerDec 01Sale45.161,00045,160432,689Dec 02 06:03 PM
Xie JianChief Operating OfficerNov 30Sale43.223,396146,762433,689Dec 02 06:03 PM
Xie JianChief Operating OfficerNov 23Sale44.086,000264,480437,085Nov 24 05:24 PM
Xie JianChief Operating OfficerNov 20Sale42.501,00042,500443,085Nov 24 05:24 PM
Xie JianChief Operating OfficerNov 18Sale44.833,000134,500444,085Nov 19 08:15 PM
BOLGER JOHN CDirectorNov 17Option Exercise0.382,6311,0004,644Nov 18 07:48 PM
Gao HanlinChief Scientific OfficerNov 17Sale45.4530113,680813,391Nov 18 07:50 PM
BOLGER JOHN CDirectorNov 17Sale44.244,269188,877375Nov 18 07:48 PM
Xie JianChief Operating OfficerNov 17Sale45.343,706168,012447,085Nov 19 08:15 PM
KIM PAULCFO and TreasurerNov 17Sale45.453,767171,206232,132Nov 18 07:52 PM
KIM PAULCFO and TreasurerNov 16Sale46.17100,0004,616,980235,899Nov 18 07:52 PM
KIM PAULCFO and TreasurerSep 02Sale28.3242512,035335,899Sep 03 08:45 PM
Xie JianChief Operating OfficerAug 28Sale30.8244113,591601,295Sep 23 07:35 PM
KIM PAULCFO and TreasurerAug 19Sale44.1625,4071,122,039335,774Aug 19 09:14 PM
BOLGER JOHN CDirectorAug 17Option Exercise12.312,63132,3935,927Aug 19 09:09 PM
KIM PAULCFO and TreasurerAug 17Sale41.65111,2364,633,097361,181Aug 19 09:14 PM
Gao HanlinChief Scientific OfficerAug 17Sale41.111,30853,7721,281,351Aug 19 09:11 PM
BOLGER JOHN CDirectorAug 17Sale40.873,914159,9672,013Aug 19 09:09 PM
KIM PAULCFO and TreasurerAug 11Sale42.061,39658,712472,417Aug 12 04:28 PM
Xie JianChief Operating OfficerAug 03Sale27.861,97655,055601,736Aug 05 08:57 PM